Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4274/balkanmedj.2017.0350 http://scihub22266oqcxt.onion/10.4274/balkanmedj.2017.0350 C5450857!5450857!28443588     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Balkan+Med+J 2017 ; 34 (3): 188-99 Nephropedia Template TP {{tp|p=28443588|t=2017. Solitary Fibrous Tumors of Chest: Another Look with the Oncologic Perspective |pdf=|usr=}}{{28443588}} gab.com Text Solitary Fibrous Tumors of Chest: Another Look with the Oncologic Perspective JO: Balkan Med J http://www.kidney.de/pget.php?&tw=1&pmid=28443588 #FOAvip Solitary ?brous tumors are mesenchymal lesions that arise at a variety of sites, most commonly the pleura. Most patients are asymptomatic at diagnosis, with lesions being detected incidentally. Nevertheless, some patients present due to symptoms from local tumor compression (eg. of the airways and pulmonary parenchyma). Furthermore, radiological methods are not always conclusive in making a diagnosis, and thus, pathological analysis is often required. In the past three decades, immunohistochemical techniques have provided a gold standard in solitary ?brous tumor diagnosis. The signature marker of solitary ?brous tumor is the presence of the NAB2-STAT6 fusion that can be reliably detected with a STAT6 antibody. While solitary ?brous tumors are most often benign, they can be malignant in 10-20% of the cases. Unfortunately, histological parameters are not always predictive of benign vs malignant solitary ?brous tumors. As solitary ?brous tumors are generally regarded as relatively chemoresistant tumors; treatment is often limited to localized treatment modalities. The optimal treatment of solitary ?brous tumors appears to be complete surgical resection for both primary and local recurrent disease. However, in cases of suboptimal resection, large disease burden, or advanced recurrence, a multidisciplinary approach may be preferable. Specifically, radiotherapy for inoperable local disease can provide palliation/shrinkage. Given their sometimes -unpredictable and often- protracted clinical course, long-term follow-up post-resection is recommended. Twit Text FOAVip Solitary Fibrous Tumors of Chest: Another Look with the Oncologic Perspective ????Balkan Med J http://www.kidney.de/pget.php?&tw=1&pmid=28443588 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28443588 #FOAvip English Wikipedia <ref>{{Cite pmid|28443588}}</ref> Solitary Fibrous Tumors of Chest: Another Look with the Oncologic Perspective #MMPMID28443588 Saynak M; Veeramachaneni NK; Hubbs JL; Okumu? D; Marks LB Balkan Med J 2017[May]; 34 (3): 188-99 PMID28443588show ga Solitary ?brous tumors are mesenchymal lesions that arise at a variety of sites, most commonly the pleura. Most patients are asymptomatic at diagnosis, with lesions being detected incidentally. Nevertheless, some patients present due to symptoms from local tumor compression (eg. of the airways and pulmonary parenchyma). Furthermore, radiological methods are not always conclusive in making a diagnosis, and thus, pathological analysis is often required. In the past three decades, immunohistochemical techniques have provided a gold standard in solitary ?brous tumor diagnosis. The signature marker of solitary ?brous tumor is the presence of the NAB2-STAT6 fusion that can be reliably detected with a STAT6 antibody. While solitary ?brous tumors are most often benign, they can be malignant in 10-20% of the cases. Unfortunately, histological parameters are not always predictive of benign vs malignant solitary ?brous tumors. As solitary ?brous tumors are generally regarded as relatively chemoresistant tumors; treatment is often limited to localized treatment modalities. The optimal treatment of solitary ?brous tumors appears to be complete surgical resection for both primary and local recurrent disease. However, in cases of suboptimal resection, large disease burden, or advanced recurrence, a multidisciplinary approach may be preferable. Specifically, radiotherapy for inoperable local disease can provide palliation/shrinkage. Given their sometimes -unpredictable and often- protracted clinical course, long-term follow-up post-resection is recommended. äSolitary Fibrous Tumors of Chest: Another Look with the Oncologic Pers(epmc).pdf DeepDyve Pubget Overpricing